Sangamo Therapeutics
SGMO
#6697
Rank
โ‚ฌ0.49 B
Marketcap
2,38ย โ‚ฌ
Share price
6.93%
Change (1 day)
572.51%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2024 (TTM): -โ‚ฌ0.13 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ52.29 Million. In 2023 the company made an earning of -โ‚ฌ0.12 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.13 Billion7.61%
2023 -โ‚ฌ0.12 Billion-40.88%
2022 -โ‚ฌ0.2 Billion9.79%
2021 -โ‚ฌ0.18 Billion41.52%
2020 -โ‚ฌ0.13 Billion23.17%
2019 -โ‚ฌ0.11 Billion36.33%
2018 -โ‚ฌ74.44 Million36.89%
2017 -โ‚ฌ54.38 Million-22.32%
2016 -โ‚ฌ70.01 Million54.86%
2015 -โ‚ฌ45.21 Million75.62%
2014 -โ‚ฌ25.75 Million0.13%
2013 -โ‚ฌ25.71 Million
2011 -โ‚ฌ34.56 Million43.66%
2010 -โ‚ฌ24.06 Million28.52%
2009 -โ‚ฌ18.72 Million-23.55%
2008 -โ‚ฌ24.49 Million2.45%
2007 -โ‚ฌ23.9 Million19.5%
2006 -โ‚ฌ20 Million50.78%
2005 -โ‚ฌ13.27 Million75%
2004 -โ‚ฌ7.58 Million-33.25%
2003 -โ‚ฌ11.36 Million-62.27%
2002 -โ‚ฌ30.1 Million102.82%
2001 -โ‚ฌ14.84 Million23.21%
2000 -โ‚ฌ12.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ0.16 B-231.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.19 Billion 39.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.51 B-3,586.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.83 B-1,520.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.99 B-866.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.74 B-13,805.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.37 B-391.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.44 B-11,255.48%๐Ÿ‡บ๐Ÿ‡ธ USA